Evidence map›Paper›PMID 20185649›Full record

ArticleAnesthesia and analgesia2010

Temporally and regionally disparate differences in plasmin activity by tranexamic acid.

Daryl L Reust, Scott T Reeves, James H Abernathy, Jennifer A Dixon, William F Gaillard, Rupak Mukherjee, Christine N Koval, Robert E Stroud, Francis G Spinale

Open access · greenAbstract read
In one paragraph

Article in Anesthesia and analgesia, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Tranexamic acid: single topical application for femoral neck fractures treated with arthroplasty results in lowest blood loss.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2025
    Article
  3. [Prophylactic use of tranexamic acid in noncardiac surgery : Update 2017].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2019
    Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Daryl L ReustDepartment of Anesthesiology and Perioperative Medicine, Medical University of South Carolina, Charleston, SC 29403, USA.
Scott T Reeves
James H Abernathy
Jennifer A Dixon
William F Gaillard
Rupak Mukherjee
Christine N Koval
Robert E Stroud
Francis G Spinale
Medical University of South Carolina · US

Funding

COLLAGENASE INHIBITION IN HEART FAILURER01HL059165 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI SPINALE, FRANCIS G · 1998 to 2010
$3.2M
Imaging of MMP activation and myocardial strainsR01HL078650 · NHLBI · YALE UNIVERSITY · PI SINUSAS, ALBERT J · 2004 to 2007
$2.3M
Continuous monitoring of anti-fibrinolytic therapy in cardiovascular surgeryR42HL099258 · NHLBI · MICRO VIDE, LLC · PI SPINALE, FRANCIS G · 2010 to 2012
$812k
NHLBI NIH HHS HL059165NHLBI NIH HHS HL078650NHLBI NIH HHS R01 HL059165NHLBI NIH HHS R01 HL078650NHLBI NIH HHS R42 HL099258
6 · The paper itself

Abstract

backgroundA major complication associated with cardiac surgery is excessive and prolonged bleeding in the perioperative period. Improving coagulation by inhibiting fibrinolysis, primarily through inhibition of plasmin activity (PLact) with antifibrinolytics such as tranexamic acid (TXA), has been a pharmacological mainstay in cardiac surgical patients. Despite its almost ubiquitous use, the temporal and regional modulation of PLact profiles by TXA remains unexplored. Accordingly, we developed a fluorogenic-microdialysis system to measure in vivo dynamic changes in PLact after TXA administration in a large animal model.

methodsPigs (25-35 kg) were randomly assigned to receive TXA (30 mg/kg, diluted into 50 mL normal saline; n = 9) or vehicle (50 mL normal saline; n = 7). Microdialysis probes were placed in the liver, myocardium, kidney, and quadriceps muscle compartments. The microdialysate infusion contained a validated plasmin-specific fluorogenic peptide. The fluorescence emission (standard fluorogenic units [SFU]) of the interstitial fluid collected from the microdialysis probes, which directly reflects PLact, was determined at steady-state baseline and 30, 60, 90, and 120 min after TXA/vehicle infusion. Plasma PLact was determined at the same time points using the same fluorogenic substrate approach.

resultsTXA reduced plasma PLact at 30 min after infusion by >110 SFU compared with vehicle values (P < 0.05). Specifically, there was a decrease in liver PLact at 90 and 120 min after TXA infusion of >150 SFU (P < 0.05) and 175 SFU (P < 0.05), respectively. The decrease in liver PLact occurred 60 min after the maximal decrease in plasma PLact. In contrast, kidney, heart, and quadriceps PLact transiently increased followed by an overall decrease at 120 min.

conclusionsUsing a large animal model and in vivo microdialysis measurements of PLact, the unique findings from this study were 2-fold. First, TXA induced temporally distinct PLact profiles within the plasma and selected interstitial compartments. Second, TXA caused region-specific changes in PLact profiles. These temporal and regional differences in the effects of TXA may have important therapeutic considerations when managing fibrinolysis in the perioperative period.

Indexed as

AnimalsAntifibrinolytic AgentsFibrin Fibrinogen Degradation ProductsFibrinolysinFibrinolysisInfusions, IntravenousKidneyLiverMaleMicrodialysisModels, AnimalMyocardiumQuadriceps MuscleReproducibility of ResultsSpectrometry, FluorescenceSwineAntifibrinolytic AgentsFibrin Fibrinogen Degradation Productsfibrin fragment DFibrinolysinTranexamic Acid

Identifiers

PMID20185649
PMCPMC2880532
OpenAlexW2088266030

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.